↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

42 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Amlodipine  4件: Amlodipine; Amlodipine gel; Calcium channel blockers (amlodipine, azelnidipine); Amlodipine (drug);   D00615
 D02914
 D07450 
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   4件:
51,
65,
67,
298
 2   Bardoxolone  4件: Bardoxolone; Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule;   D09584   -   -   7件:
66,
67,
84,
85,
86,
218,
222
 3   Bardoxolone methyl  3件: Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule;   D09585   -   -   7件:
66,
67,
84,
85,
86,
218,
222
 4   Bendroflumethiazide  1件: Bendroflumethiazide;   D00650   -   -   1件:
67
 5   Bisoprolol  2件: Bisoprolol; Bisoprolol fumarate;   D00634
 D02342 
 1件: ADRB1   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Neuroactive ligand-receptor interaction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
67,
86,
113
 6   Bosutinib  1件: Bosutinib;   D03252   2件: ABL1, SRC   3件: Chronic myeloid leukemia, ErbB signaling pathway, Pathways in cancer   2件:
2,
67
 7   Candesartan  1件: Candesartan;   D00522   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
58,
67
 8   Candesartan cilexetil  0件:   D00522
 D00626 
 1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
58,
67
 9   Cilnidipine  1件: Cilnidipine;   D01173   5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   1件:
67
 10   Curcumin  6件: Curcumin; Ifn beta 1 a + curcumin (bcm 95); Nanocurcumin; Curcumin (longvida™); Curcumin supplement; Bio-enhanced curcumin soft gelatin capsule;   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299
 11   Doxazosin  2件: Doxazosin; Metoprolol succinate + doxazosin;   D00608
 D07874 
 3件: ADRA1A, ADRA1B, ADRA1D   3件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   2件:
57,
67
 12   Emodin  1件: Emodin;   -   -   -   1件:
67
 13   Everolimus  6件: Everolimus; Everolimus (rad001); Everolimus (rad001) , afinitor®; Rad001, everolimus; Rad001: everolimus; Afinitor (everolimus);   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   9件:
34,
67,
89,
96,
137,
157,
158,
228,
277
 14   Hydralazine  1件: Hydralazine;   D01302
 D08044 
 -   -   1件:
67
 15   Hydrochlorothiazide  2件: Hydrochlorothiazide; Hydrochlorothiazide/amiloride;   D00340   -   -   3件:
13,
67,
225
 16   Imidapril  1件: Imidapril;   D08068   1件: ACE   1件: Renin-angiotensin system   1件:
67
 17   L-Arginine  3件: L-arginine; Ng-monomethyl-l-arginine; Ng-monomethyl-l-arginine (drug);   D02982   -   -   5件:
67,
78,
113,
251,
299
 18   Lanreotide  2件: Lanreotide; Lanreotide acetate;   D04666   -   -   4件:
67,
73,
85,
298
 19   Lisinopril  3件: Lisinopril; Coenzyme q10 and lisinopril; Lisinopril, losartan, and atorvastatin;   D00362
 D08131 
 1件: ACE   1件: Renin-angiotensin system   5件:
46,
66,
67,
113,
222
 20   Lixivaptan  1件: Lixivaptan;   D04752   1件: AVPR2   2件: Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption   1件:
67
 21   Losartan  8件: Losartan; Losartan bluefish 50 mg; Sildenafil and losartan; Losartan potassium; Losartan and atenolol or propranolol; Losartan potasico; Lisinopril, losartan, and atorvastatin; Losartan tablets & qingremoshen granule;   D00357
 D08146 
 1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299
 22   Metformin  15件: Metformin; Glucophage (metformin); Metformin/cp-690,550; Metformin hydrochloride; Metformine; Metformine sandoz 850 mg filmomhulde tabletten; 750 mg metformin and 7.5 g l-citrulline daily p.o.; L-citrulline and metformin & l-citrulline; Metformin 500mg; Metformin and metformin & l-citrulline; Metformin (generic); Sitagliptin and metformin; Pioglitazone or metformin; Metformin hcl; Metformine hcl 500 pch;   D00944
 D04966 
 2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   17件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285,
299
 23   Nicotinamide  2件: Nicotinamide; Nicotinamide riboside;   D00036   -   -   8件:
5,
6,
13,
46,
49,
53,
67,
162
 24   Octreotide  5件: Octreotide; Octreotide lar; Octreotide-lar; Gallium-68-dota-n-octreotide; Octreotide lar / sandostatin lar (lar=long acting release);   D00442
 D06495 
 1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   8件:
67,
75,
84,
85,
89,
96,
193,
227
 25   Pasireotide  7件: Pasireotide; Pasireotide lar; Pasireotide 0.6 mg/ml; Pasireotide diaspartate; Pasireotide pamoate; Pasireotide s.c.; Pasireotide with or without cabergoline;   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
67,
74,
75
 26   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 27   Potassium  5件: Dipotassium salt; Potassium; Potassium supplement; Losartan potassium; Potassium sparing diuretic;   D08403   -   -   9件:
46,
66,
67,
98,
115,
167,
179,
215,
235
 28   Pravastatin  4件: Pravastatin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; Pravastatin sodium; Lonafarnib, zoledronic acid, and pravastatin;   D00893
 D08410 
 1件: HMGCR   2件: Bile secretion, Terpenoid backbone biosynthesis   9件:
13,
46,
49,
67,
79,
96,
164,
265,
333
 29   Ramipril  1件: Ramipril;   D00421   1件: ACE   1件: Renin-angiotensin system   7件:
46,
49,
66,
67,
113,
218,
257
 30   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 31   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 32   Somatostatin  2件: Long-acting somatostatin; Somatostatin;   D07431   5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5   2件: Gastric acid secretion, Neuroactive ligand-receptor interaction   2件:
67,
78
 33   Spironolactone  4件: Spironolactone; Ambrisentan plus spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol;   D00443   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   6件:
58,
67,
86,
113,
218,
225
 34   Telmisartan  1件: Telmisartan;   D00627   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
66,
67
 35   Tesevatinib  2件: Kd019 (tesevatinib); Tesevatinib;   -   -   -   1件:
67
 36   Tilarginine  0件:   -   -   -   1件:
67
 37   Tolvaptan  15件: Jinarc - tolvaptan tablets; Opc-41061 (tolvaptan); Tolvaptan; Tolvaptan (opc-41061); Tolvaptan 15 mg tablet; Tolvaptan 15 mg tablets; Tolvaptan 15mg; Tolvaptan 30 mg tablet; Tolvaptan 30 mg tablets; Tolvaptan 30mg; Tolvaptan 7.5 mg tablet; Tolvaptan ir; Tolvaptan mr; Tolvaptan in euvolemic hyponatremia; Tolvaptan oral tablet;   D01213   1件: AVPR2   2件: Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption   3件:
67,
72,
225
 38   Tripterygium wilfordii whole  0件:   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271
 39   Triptolide  2件: Triptolide; Triptolide-containing formulation;   -   -   -   1件:
67
 40   Ursodeoxycholic acid  13件: Ursodeoxycholic acid; Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules; Udca (ursodeoxycholic acid); Ursodeoxycholic acid (urso); Ursodeoxycholic acid 300mg capsule; Ursodeoxycholic acid 300mg tablet; Ursodeoxycholic acid capsules; Ursodeoxycholic acid combination of immunosuppressive agents; Norursodeoxycholic acid; Ursodeoxycholic acid (udca); Tauroursoursodeoxycholic acid, brand name tudcabil; Ursodiol (ursodeoxycholic acid, udca);   D00734   1件: NR1H4   1件: Bile secretion   12件:
6,
8,
20,
67,
84,
93,
94,
95,
96,
97,
234,
299
 41   Venglustat  3件: Venglustat; Venglustat gz/sar402671; Venglustat gz402671;   D11633   1件: UGCG   1件: Sphingolipid metabolism   2件:
19,
67
 42   Water  13件: 5% glucose water solution; Water; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; 15 o water; Water for injection; 15-o labeled water; Pl 12185/0002 & pl 12185/0005(water for injection); Dextrose, 5% in water; High water intake; Lactose in water; Water for injections; Water for injections, ep;   D00001   -   -   22件:
2,
5,
6,
13,
17,
19,
28,
35,
46,
53,
57,
63,
65,
67,
78,
84,
97,
193,
226,
271,
278,
299

先頭へ